Viking Therapeutics Inc.

VKTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$30.11

+$1.12 (+3.86%)

At close: Sep 21, 2026, 4:00 PM ET

$30.65

+$0.54 (+1.79%)

After-hours: Sep 21, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	431K	n/a	n/a	n/a	n/a	n/a
Gross Profit	-431K	n/a	n/a	n/a	n/a	n/a
Operating Income	-393.34M	-150.92M	-100.83M	-70.36M	-55.68M	-42.66M
Interest Income	33.7M	40.94M	15.02M	1.59M	703K	3.23M
Pretax Income	-359.64M	-109.96M	-85.9M	-68.87M	-54.99M	-39.5M
Net Income	-359.64M	-109.96M	-85.9M	-68.87M	-54.99M	-39.5M
Selling & General & Admin	48.39M	49.28M	37.02M	16.12M	10.7M	10.73M
Research & Development	344.96M	101.64M	63.81M	54.23M	44.98M	31.93M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	393.34M	150.92M	100.83M	70.36M	55.68M	42.66M
Interest Expense	56K	94K	88K	59K	18K	106K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	393.34M	150.92M	100.83M	70.36M	55.68M	42.66M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	112.67M	109.04M	94.35M	76.83M	77.2M	72.6M
Shares Outstanding (Diluted)	112.67M	109.04M	94.35M	76.83M	77.2M	72.6M
EPS (Basic)	-3.19	-1.01	-0.91	-0.88	-0.70	-0.50
EPS (Diluted)	-3.19	-1.01	-0.91	-0.88	-0.70	-0.50
EBITDA	-359.15M	-109.52M	-85.52M	-68.52M	-54.68M	-39.11M
EBIT	-359.58M	-109.87M	-85.81M	-68.81M	-54.97M	-39.39M
Depreciation & Amortization	431K	346K	292K	291K	296K	277K